Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Different factors affect where drugs are absorbed in the small intestine, which is important for effective medication use.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Some medications can cause acne, and stopping these drugs is the main treatment.

Treating cystoid macular oedema in uveitis is difficult and risky.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Both treatments for pemphigus foliaceus in dogs are effective, but combination therapy has more side effects.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Early treatment of superficial fungal infections in immunocompromised patients is crucial.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Prominin-1 expressing cells in the dermal papilla help regulate hair follicle size and communication but don't aid in skin repair.